Download as PPSX, PPTX
Uploaded byDr Ketan Ranpariya
Post exposure prophylaxis PEP
The document provides guidelines for safe injection practices as part of a health awareness campaign led by Dr. Ketan Ranpariya. It identifies body fluids considered infectious and outlines precautions healthcare personnel should take to avoid exposure to potentially hazardous materials. The document emphasizes the importance of using protective gear and following universal precautions in healthcare settings.
In this document
Powered by AI
Dr. Ketan Ranpariya introduces PEP in the context of HIV/AIDS care.
The information is intended for healthcare personnel to promote safe injection practices without financial motives.
Repetitive mention of Dr. Ketan Ranpariya as the main speaker.
Overview of seroconversion risks due to percutaneous injuries based on CDC data from 2001.
Discussion of which body fluids are infectious, listing several bodily fluids like blood, saliva, and others.
Categorization of body fluids into 'at risk' and 'not at risk', emphasizing those with visible blood.
Continued focus on Dr. Ketan Ranpariya without additional content.
Information on accessing PEP posters via Dr. Ketan Ranpariya's Facebook page.
Emphasis on universal precautions, the importance of protective gear, and safe handling of sharps.
Thank you note and information on participating in the safe injection practice campaign with contact details.
More Related Content
Similar to Post exposure prophylaxis PEP
![Hiv aids part 4[3]](https://cdn.slidesharecdn.com/ss_thumbnails/hivaidspart43-111114103254-phpapp01-thumbnail.jpg?width=640&height=640&fit=bounds)
Post exposure prophylaxis PEP
- 1. Post Exposure Prophylaxis(PEP) Dr Ketan Ranpariya (MBBS, PGDHM,PGDHIVM,HIVM) HIV / AIDS CONSULTANAT Mobile: 0 75 75 88 70 70
- 2. Disclaimer • This informationis for Awareness of Health Care Personnel as part of “Safe Injection Practice” Campaign 10 K. • I do not have anything for financial disclosure. It’s release for Public Health Interest • Have a Safe and Healthy Injection Practice and keep yourself and patient safe. • Let’s Join Hand and Work Together to achieve Harmless Injection Practice Dr Ketan Ranpariya
- 3.
- 4.
- 5. Source: CDC. MMWR2001;50(RR11): 1-42 Relative Risk of Seroconversion with Percutaneous Injury Dr Ketan Ranpariya
- 6. Body Fluids: Whichare infectious and which are not infectious ??? • Sweat • Blood • Saliva • Semen • Sputum • Vaginal Secretion • Vomitus • CSF • Synovial, Pleural, Pericardial, Peritoneal fluid • Urine / Stool • Amniotic fluid • Tear Dr Ketan Ranpariya
- 7. Potentially Infectious BodyFluid Exposure to body fluid considered “at risk” Exposure to body fluid considered “not at risk” Any body fluid contaminated with “visible blood” shall be considered “at risk” Dr Ketan Ranpariya
- 8. Potentially Infectious BodyFluid Exposure to body fluid considered “at risk” Exposure to body fluid considered “not at risk” Blood Semen Vaginal Secretion CSF Synovial, Pleural, Pericardial, Peritoneal fluid Amniotic fluid Any body fluid contaminated with “visible blood” shall be considered “at risk” Dr Ketan Ranpariya
- 9. Potentially Infectious BodyFluid Exposure to body fluid considered “at risk” Exposure to body fluid considered “not at risk” Blood Tear Semen Sweat Vaginal Secretion Urine / Faeces CSF Saliva Synovial, Pleural, Pericardial, Peritoneal fluid Sputum Amniotic fluid Vomitus Any body fluid contaminated with “visible blood” shall be considered “at risk” Dr Ketan Ranpariya
- 10.
- 11.
- 12.
- 13.
- 14.
- 15.
- 16. PEP poster avialableon facebook page: DrKetan Ranpariya HIV specialist Dr Ketan Ranpariya
- 17. Universal Precautions Prevention isthe key step! Always use protective gear Consider all blood samples infectious Follow universal precaution Safe Handling of Sharps Use needle destroyer Dr Ketan Ranpariya
- 18. Thank You !!! DrKetan Ranpariya
- 19. To Participate in “SafeInjection Practice” Campaign 10 K You can contact us on : 0 70 48 70 41 41 : www.facebook.com/HIVCLINICSURAT : [email protected] : www.hivaidssurat.com Dr Ketan Ranpariya
Editor's Notes
- #2 Step 1: Introduction and session objectives (Slide 1-2) - 2 minutes Trainer Notes: This session should take approximately 60 minutes to implement. Step 1: Introduction and session objectives (Slides 1-2) - 2 minutes Step 2: Exercise 1: Story Time (Slide 3) - 3 minutes Step 3: Presentation of Transmission of HIV, infectious body fluids and risk of transmission (Slides 4-8) – 10 minutes Step 4: Presentation of Elements of Post-Exposure Management (Slides 9- 10) – 5 minutes Step 5: Categorising and Assessing Exposure Codes (Slides 11-15) – 12 minutes Step 6: PEP and Health Care Workers, including PEP Register (Slides 16-30) – 22 minutes Step 7: Prevention aspects and PEP (Slides 31-32) – 4 minutes Step 8: Summary (Slide 33) – 2 minutes
- #6 Trainer Notes: This graph clearly shows that Hepatitis B has the highest risk of transmission when compared to HIV and Hepatitis C and especially if the tests prove positive for both HBsAg and HBeAg. Although the number of HIV infections acquired occupationally remains low, it is the pathogen of greatest interest. The risk of transmission of HIV occupationally is negligible. In prospective studies of healthcare personnel, the average risk after a Percutaneous exposure is about 3 per 1000; and <1 in a 1000 with mucus membrane exposure. Although transmission through non intact skin and by fluids has been reported, they are highly unusual. Even in the absence of any intervention, most exposures do not result in infection. In contrast, the risk of transmission of hepatitis B is far higher. The risk of transmission of hepatitis B is related to the status of the source patient. A source patient who is hepatitis B e antigen positive (active replicator), the risk of transmission is 40-60%; in the patient who is hepatitis B e antigen negative, the risk of transmission is 20-40%. Transmission of hepatitis C is intermediate, at about 2%. For further study refer to Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Post-Exposure Prophylaxis, CDC. MMWR 2001; 50 (RR11):1-42.
- #8 Trainer Notes: Describe the Potentially Infectious Body Fluids. using the slide contents.
- #9 Trainer Notes: Describe the Potentially Infectious Body Fluids. using the slide contents.
- #10 Trainer Notes: Describe the Potentially Infectious Body Fluids. using the slide contents.
- #18 Trainer Notes: Discuss the Universal Precautions to the participants, using the slide contents.